You are here
mmr still after 5 years
Categories:
Consider drug rotation:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540367/
From the article:
"Moreover, the simulations give credence to the suggestion that lower drug concentrations may achieve better results following major molecular response in CML."
Changing to a low dose second-line drug may very well wipe out residual disease (resistant clones to imatinib).
